Wordt geladen...

Adverse events in patients initiated on dabigatran etexilate therapy in a pharmacist- managed anticoagulation clinic

Background : Vitamin K antagonists have been the treatment of choice in preventing thromboembolic events, but problems such as frequent dose adjustment and monitoring of coagulation status, including multiple drug and food interactions, make their use difficult. Dabigatran etexilate is a new oral di...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Pharmacy Practice
Hoofdauteurs: Mark DONALDSON, Amber O. NORBECK
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Centro de investigaciones y Publicaciones Farmacéuticas 2013
Onderwerpen:
Online toegang:https://www.redalyc.org/articulo.oa?id=69028370004
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!